As illustrated in Figure 3B, serum IL-6 levels were significantly higher in the NASH group than in the control group (262.71 ± 12.49 vs. 199.57 ± 23.69 pg/mL, respectively, p < 0.05). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.